Soliton Reports First Quarter 2021 Results News provided by Share this article Share this article HOUSTON, May 12, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the first quarter ended March 31, 2021. Recent Company Highlights: Selected RESONIC™ as the brand name for the Company's Rapid Acoustic Pulse (RAP) device; Received FDA Special 510(k) clearance for modifications to the RESONIC device to facilitate ease of use in commercial settings; Successfully completed all required safety testing including Quality System/Current Good Manufacturing Practice regulations for medical devices (21 CFR Part 820) inspection from the FDA;